| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |